The pharmacokinetics and pharmacodynamics of medifoxamine after oral administration in healthy elderly volunteers

Gainsborough, N, Nelson, M L, Maskrey, V, Swift, C G and Jackson, S H (1994) The pharmacokinetics and pharmacodynamics of medifoxamine after oral administration in healthy elderly volunteers. European Journal of Clinical Pharmacology, 46 (2). pp. 163-166. ISSN 0031-6970

Full text not available from this repository.

Abstract

The pharmacokinetics and psychomotor effects of medifoxamine, a 5 HT reuptake inhibitory antidepressant, were studied in healthy elderly volunteers after single and multiple dosing. The elimination half life (t1/2z) after single doses of 300 mg was 2.8 h--almost identical to that found in young volunteers. After seven days of dosing at 100 mg three times daily the mean corrected AUC after 300 mg significantly increased from 1.04 to 1.34 mg.h.l-1 and t1/2z increased to 4.0 h (NS). There were no significant changes in critical flicker fusion frequency, symbol digit substitution, continuous attention or choice reaction times.

Item Type:	Article
Uncontrolled Keywords:	administration, oral,aged,antidepressive agents,ethylamines,female,half-life,humans,male,psychomotor performance,reference values
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	Pure Connector
Date Deposited:	30 Apr 2015 12:28
Last Modified:	21 Oct 2022 00:50
URI:	https://ueaeprints.uea.ac.uk/id/eprint/53210
DOI:	10.1007/BF00199882

Actions (login required)

View Item